Financial Performance - Operating revenue for the current period was CNY 25,040,726.07, a slight increase of 0.22% from CNY 24,986,300.53 in the same period last year[7] - Net profit attributable to shareholders of the listed company was a loss of CNY 6,472,362.04, compared to a loss of CNY 3,426,561.34 in the previous year[7] - Basic and diluted earnings per share were both -0.0406 CNY, compared to -0.0278 CNY in the previous year[7] - Operating profit for Q1 2016 was reported at a loss of CNY 6,153,504.08, compared to a loss of CNY 3,313,209.03 in the same period last year[28] - The net profit for Q1 2016 was a loss of CNY 5,155,675.24, compared to a loss of CNY 3,340,870.01 in Q1 2015, indicating a worsening performance[32] - The total comprehensive loss for Q1 2016 was CNY 5,155,675.24, compared to a loss of CNY 3,340,870.01 in the previous year[32] Cash Flow - Cash flow from operating activities showed a loss of CNY 1,015,044.11, an improvement from a loss of CNY 5,625,090.30 in the same period last year[7] - The net cash flow from operating activities improved by 81.96%, reducing outflows to RMB -1,015,044.11 from RMB -5,625,090.30[15] - The cash inflow from operating activities totaled CNY 22,827,294.71, down from CNY 27,881,775.92 in the same period last year[34] - Operating cash inflow for the current period was CNY 13,220,884.14, an increase of 8.7% compared to CNY 12,163,007.09 in the previous period[36] - Net cash flow from operating activities was CNY 721,582.23, a significant improvement from a net outflow of CNY -353,842.42 in the same period last year[37] - Cash inflow from financing activities was CNY 20,000,000.00, a substantial increase from CNY 700,000.00 in the prior period[37] - Net cash flow from financing activities was CNY 14,787,996.42, a turnaround from a net outflow of CNY -200,000.00 last year[37] Assets and Liabilities - Total assets increased by 7.74% to CNY 302,071,710.04 compared to the end of the previous year[7] - The total liabilities increased to CNY 244,167,522.59 from CNY 217,625,835.78, marking an increase of 12.16%[25] - Current liabilities totaled CNY 209,884,929.83, up from CNY 183,127,930.65, indicating a growth of 14.66%[24] - The company's total assets reached CNY 302,071,710.04, compared to CNY 280,382,217.55 at the beginning of the year, an increase of 7.45%[25] - The company's short-term borrowings increased to CNY 109.5 million from CNY 87 million, indicating a rise in leverage[23] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,719[12] - The largest shareholder, Changcheng Film and Television Culture Group, held 22.15% of shares, amounting to 26,971,020 shares[12] Expenses - The company's sales expenses grew by 20.20% to RMB 3,017,401.15, driven by an increase in sales revenue[14] - Management expenses surged by 66.53% to RMB 9,609,469.28, mainly due to severance payments and costs associated with work stoppages[14] - The company incurred sales expenses of CNY 2,199,071.52 in Q1 2016, an increase from CNY 1,696,954.77 in Q1 2015[32] Inventory and Receivables - Accounts receivable rose by 30.70% to RMB 26,004,228.39, with the parent company contributing an increase of RMB 3.1656 million and the mint company adding RMB 3.1810 million[14] - Inventory levels increased to CNY 73.47 million from CNY 65.82 million, reflecting a buildup of stock[23] Future Expectations - The company expects to achieve approximately CNY 55 million in sales revenue for the first half of 2016, representing a growth of about 26% compared to the same period last year[20] - The company anticipates a loss of around CNY 8 million for the first half of 2016, which is an increase in loss of approximately 30% year-over-year, primarily due to costs associated with GMP renovations at its manufacturing centers[20] Asset Restructuring - The company is in the process of a major asset restructuring, having approved a plan to issue shares and pay cash for asset purchases on December 15, 2015[15] - The company has decided to terminate its major asset restructuring plan due to disagreements with the counterparty regarding business direction and management[18] - The company is committed to not discussing any major asset restructuring matters for three months following the investor communication on April 6, 2016[20] Non-Recurring Items - The company reported non-recurring gains and losses totaling CNY 1,527,544.18 for the current period[9] - The company reported a 39.63% decrease in non-operating income, dropping to RMB 1,550,299.82, mainly due to reduced compensation from work stoppages[15]
*ST目药(600671) - 2016 Q1 - 季度财报